Literature DB >> 8283265

Intracellular mechanisms involved in the responses of cerebrovascular smooth-muscle cells to hemoglobin.

B A Vollrath1, B K Weir, R L Macdonald, D A Cook.   

Abstract

An investigation was undertaken of the mechanism by which oxyhemoglobin and its analog methemoglobin might cause cerebrovascular spasm. The effect of these compounds on the levels of intracellular inositol triphosphate and calcium in cultured primate cerebrovascular smooth-muscle cells and the contractile action of oxyhemoglobin on isolated rings of primate cerebral arteries were also examined. Oxyhemoglobin, but not methemoglobin, produces a transient but highly significant increase in the intracellular levels of inositol triphosphate. Intracellular calcium levels in these cells are increased by thrombin, aluminum tetrafluoride, and oxyhemoglobin, and the sustained elevation in intracellular calcium is prevented by ethyleneglycol tetra-acetic acid and the phospholipase C inhibitor neomycin. Removal of the oxyhemoglobin after as long as 48 hours' incubation with this compound allowed cells to rapidly reduce their intracellular calcium levels to near normal. Oxyhemoglobin produced contractions of isolated rings of both normal and spastic cerebral arteries, although the response of spastic vessels was significantly smaller. This effect was inhibited by neomycin. The addition of neomycin relaxed arteries that were contracted with oxyhemoglobin, 5-hydroxytryptamine, or potassium chloride. It is thus likely that activation of phospholipase C is a critical step in the development of vasospasm, but the transient nature of the response to inositol triphosphate suggests that the sustained contraction may arise from other phospholipase C-dependent mechanisms.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8283265     DOI: 10.3171/jns.1994.80.2.0261

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  6 in total

1.  Prognosis of ultra-early microsurgery combined with extraventricular drainage in patients with poor-grade aneurysms.

Authors:  Jian-Qing He; Jun-Hui Chen; Jun Zhu; Lei Chen; Chun-Lei Zhang; Li-Kun Yang; Yu-Hai Wang; Jun Zou; Xu Hu
Journal:  Int J Clin Exp Med       Date:  2015-06-15

2.  The polycationic aminoglycosides modulate the vasoconstrictive effects of endothelin: relevance to cerebral vasospasm.

Authors:  G Wickman; M A Nessim; D A Cook; B Vollrath
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

3.  Cerebral vasospasm and intracerebral haemorrhage in a case of pregnancy-related thrombotic thrombocytopoenic purpura/haemolytic uraemic syndrome.

Authors:  I C Duncan
Journal:  Interv Neuroradiol       Date:  2005-10-25       Impact factor: 1.610

Review 4.  Antioxidant therapy against cerebral vasospasm following aneurysmal subarachnoid hemorrhage.

Authors:  T Asano; T Matsui
Journal:  Cell Mol Neurobiol       Date:  1999-02       Impact factor: 5.046

5.  Oxyhemoglobin-induced expression of R-type Ca2+ channels in cerebral arteries.

Authors:  Timothy E Link; Kentaro Murakami; Micah Beem-Miller; Bruce I Tranmer; George C Wellman
Journal:  Stroke       Date:  2008-04-24       Impact factor: 7.914

6.  A glutamate receptor antagonist, S-4-carboxyphenylglycine (S-4-CPG), inhibits vasospasm after subarachnoid hemorrhage in haptoglobin 2-2 mice [corrected].

Authors:  Tomas Garzon-Muvdi; Gustavo Pradilla; Jacob J Ruzevick; Matthew Bender; Lindsay Edwards; Rachel Grossman; Ming Zhao; Michelle A Rudek; Gregory Riggins; Andrew Levy; Rafael J Tamargo
Journal:  Neurosurgery       Date:  2013-10       Impact factor: 4.654

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.